Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05326230

A Clinical Study of the Paradise™ Renal Denervation System in Patients With Hypertension (RADIANCE-HTN DUO)

A Clinical Study of the Ultrasound Renal Denervation System (PRDS-001) in Patients With Hypertension

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
154 (estimated)
Sponsor
Otsuka Medical Devices Co., Ltd. Japan · Industry
Sex
All
Age
20 Years – 75 Years
Healthy volunteers
Not accepted

Summary

To compare the antihypertensive effect of renal denervation with the Paradise™ system with that of a sham procedure in hypertensive patients receiving two antihypertensive drugs at the time of consent, and treated with a duo combination antihypertensive pill.

Conditions

Interventions

TypeNameDescription
DEVICEParadise™ (PRDS-001) Renal Denervation Ultrasound SystemFollowing renal angiogram according to standard procedures, subjects remain blinded and are randomized to treatment with renal denervation or sham control
DEVICERenal AngiogramFollowing renal angiogram according to standard procedures, subjects remain blinded and renal angiogram is considered the sham procedure

Timeline

Start date
2022-07-01
Primary completion
2026-12-01
Completion
2032-12-01
First posted
2022-04-13
Last updated
2026-04-15

Locations

51 sites across 1 country: Japan

Source: ClinicalTrials.gov record NCT05326230. Inclusion in this directory is not an endorsement.